Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
RGNX
RGNX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest RGNX ETF News Today | Earnings, Events & Price Alerts
RGNX News
REGENXBIO Presents RGX-202 Gene Therapy Updates at MDA Conference
24m ago
PRnewswire
Notice of Class Action Lawsuit Against REGENXBIO Securities
15h ago
PRnewswire
REGENXBIO Faces Class Action Lawsuit
1d ago
PRnewswire
REGENXBIO to Participate in Multiple Investor Conferences
2d ago
PRnewswire
Notice of REGENXBIO Securities Class Action
2d ago
Globenewswire
REGENXBIO Faces Securities Litigation Investigation
4d ago
PRnewswire
FDA Raises Concerns Over Invasive Gene Therapies
5d ago
stocktwits
Class Action Lawsuits Filed Against PayPal and REGENXBIO
5d ago
Globenewswire
Reminder of REGENXBIO Securities Class Action
5d ago
Globenewswire
FDA Tightens Stance on Rare Disease Drug Approvals
5d ago
stocktwits
REGENXBIO Investors Class Action Notice Issued
5d ago
Globenewswire
REGENXBIO to Host Conference Call for Q4 and Full Year Financial Results
Feb 25 2026
PRnewswire
REGENXBIO to Host Conference Call for Q4 and Full Year Results
Feb 25 2026
Newsfilter
REGENXBIO Faces Class Action Lawsuit Reminder
Feb 24 2026
Globenewswire
REGENXBIO Shareholder Notice Issued
Feb 24 2026
PRnewswire
Class Action Lawsuit Announced for REGENXBIO Investors
Feb 23 2026
Globenewswire
Show More News
